EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology-Reference-Cited by-同舟云学术

EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology

Published:2015-12-31 Issue:3 Volume:88 Page:460-465
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Boersma Lucas V.A.¹,Schmidt Boris²,Betts Tim R.³,Sievert Horst⁴,Tamburino Corrado⁵,Teiger Emmanuel⁶,Stein Kenneth M.⁷,Bergmann Martin W.⁸

Affiliation:

1. Department of Cardiology; St. Antonius Hospital; Nieuwegein The Netherlands

2. Department of Cardiology; Cardioangiologisches Centrum Bethanien; Frankfurtt Germany

3. Department of Cardiology; John Radcliffe Hospital; Oxford United Kingdom

4. Department of Cardiology; Cardio Vasculäres Centrum Sankt Katharinen; Frankfurt Germany

5. Department of Cardiology; Ospedale Ferrarotto Alessi; Catania Italy

6. Department of Cardiology; CHU Henri Mondor; Créteil France

7. Department of Cardiology; Boston Scientific Corp; Minneapolis USA

8. Department of Cardiology; Herzkatheter Asklepios Wandsbek; Hamburg Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26358/fullpdf

Reference26 articles.

1. ACC/AHA/ESC 2006 guidelines for the management of patients with AF-Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with AF);Fuster;J Am Coll Cardiol,2006

2. Factors associated with ischemic stroke during aspirin therapy in AF: Analysis of 2012 participants in the SPAF I-III clinical trials. The stroke prevention in AF (SPAF) investigators;Hart;Stroke,1999

3. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation;Camm;Eur Heart J,2012

4. Comparison of outcomes among patients randomized to VKA therapy according to anticoagulant control: Results from SPORTIF III and V;White;Arch Intern Med,2007

5. Benefit of oral anticoagulant over antiplatelet therapy in AF depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range;Connolly;Circulation,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis;PLOS ONE;2024-02-14

2. Hemorrhagic Transformation in Patients With Ischemic Stroke and Atrial Fibrillation: To Anticoagulate or Not, That Is the Question;Cureus;2024-02-04

3. Sex‐related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry;Catheterization and Cardiovascular Interventions;2023-07-02

4. Wie antikoaguliert man ältere und fragile Patienten?;Geriatrie up2date;2022-07

5. Percutaneous Left Atrial Appendage Closure: Review of Anatomy, Imaging, and Outcomes;Current Treatment Options in Cardiovascular Medicine;2022-03-01